Glimbax (Diclofenac)

Glimbax is prescribed for conditions where pain and inflammation need to be managed. It is commonly used in the following situations:

• Relief of mild to moderate pain associated with musculoskeletal disorders such as sprains, strains, and back pain.
• Reduction of inflammation in conditions like osteoarthritis and rheumatoid arthritis.
• Management of postoperative pain following minor surgical procedures.
• Treatment of acute pain episodes, for example, dental pain or soft‑tissue injuries.
• Adjunct therapy for chronic inflammatory conditions when other NSAIDs are insufficient.

Side effects of Glimbax vary in frequency and severity. Common reactions are usually mild and transient, while serious events are less frequent but require medical attention.

Common

• Gastrointestinal discomfort, such as nausea, dyspepsia, or abdominal pain.
• Headache or dizziness.
• Mild skin rash or itching.
• Elevated blood pressure.
• Mild elevation of liver enzymes.

Serious

• Gastrointestinal ulceration or bleeding.
• Severe skin reactions, including Stevens‑Johnson syndrome.
• Hepatotoxicity with jaundice.
• Renal impairment or acute kidney injury.
• Cardiovascular events such as myocardial infarction or stroke.

Before using Glimbax, certain precautions should be considered to minimize risks. Patients should discuss the following with their healthcare provider:

• History of gastrointestinal ulcers, bleeding, or chronic NSAID use.
• Existing cardiovascular disease, hypertension, or risk factors for heart disease.
• Renal or hepatic impairment, as dose adjustment may be required.
• Pregnancy, lactation, or plans to become pregnant, given limited safety data.
• Concomitant use of other NSAIDs, anticoagulants, or corticosteroids.
• Allergic reactions to diclofenac or other NSAIDs.

Glimbax can interact with several drug classes, affecting efficacy or safety. Interactions are grouped by level of concern.

Avoid

• Anticoagulants (e.g., warfarin) due to increased bleeding risk.
• Other NSAIDs or COX‑2 inhibitors, which may amplify gastrointestinal toxicity.
• Certain antihypertensives (e.g., ACE inhibitors, diuretics) that can reduce renal function.

Use with caution

• Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents, which may increase bleeding.
• Lithium, as NSAIDs can raise serum lithium levels.
• Methotrexate, where NSAIDs may reduce clearance and raise toxicity.
• Corticosteroids, which together heighten ulcer risk.